Document is current
Any future updates will be listed below
-
Authors
Wu, Yan
Wang, Pengli https://orcid.org/0000-0002-6368-0627
Liu, Lan Xiang
Song, Daesun https://orcid.org/0000-0002-6206-2034
Qin, Qin
Gao, Chao https://orcid.org/0000-0003-3662-6518
Hageman, Matt
Kirkland, Thomas A https://orcid.org/0000-0003-0859-5785
Su, Yichi https://orcid.org/0000-0001-5715-835X
Lin, Michael Z https://orcid.org/0000-0002-0492-1961
-
Funding
Funding for this research was provided by:
HHS | NIH | National Institute on Drug Abuse (1R21DA048252)
HHS | NIH | National Institute of Neurological Disorders and Stroke (1R21NS122055)
Bio-X Interdisciplinary Initiatives Program Seed Grant
Stanford Bio-X PhD Fellowship
Stanford Wu Tsai Neurosciences Institute Interdisciplinary Graduate Fellowship
- License Information
-
More Information
Article History
Received: 11 May 2025
Revised: 17 March 2026
Accepted: 2 April 2026
First Online: 23 April 2026
Disclosure and competing interests statement
: Y.W. is a current employee of Genentech, but this work was performed at Stanford University independently of that affiliation. CG, MH, and TAK are employees of Promega Corporation. TAK is a patent inventor for NanoLuc substrates used in this study. MZL and PW are inventors on a patent application for the monotemplated microbe-independent deep assembly and screening methods described in this study. The remaining authors declare no competing interests.
